These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37744403)

  • 21. Inoculation of the
    Soto M; Ramírez L; Solana JC; Cook ECL; Hernández-García E; Requena JM; Iborra S
    Microorganisms; 2021 Feb; 9(2):. PubMed ID: 33673117
    [No Abstract]   [Full Text] [Related]  

  • 22. Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB/c mice.
    Dey R; Dagur PK; Selvapandiyan A; McCoy JP; Salotra P; Duncan R; Nakhasi HL
    J Immunol; 2013 Mar; 190(5):2138-49. PubMed ID: 23338240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization of Experimental Dogs With Salivary Proteins From
    Abbehusen MMC; Cunha J; Suarez MS; Teixeira C; Almeida VDA; Pereira LDS; Bordoni M; Gil-Santana L; Solcà MDS; Fraga DBM; Fischer L; Bozza PT; Veras PST; Valenzuela JG; Kamhawi S; Andrade BB; Brodskyn CI
    Front Immunol; 2018; 9():2558. PubMed ID: 30519235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis.
    Karmakar S; Volpedo G; Zhang WW; Lypaczewski P; Ismail N; Oliveira F; Oristian J; Meneses C; Gannavaram S; Kamhawi S; Hamano S; Valenzuela JG; Matlashewski G; Satoskar AR; Dey R; Nakhasi HL
    NPJ Vaccines; 2022 Dec; 7(1):157. PubMed ID: 36463228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like Receptor-9 (TLR-9) Signaling Is Crucial for Inducing Protective Immunity following Immunization with Genetically Modified Live Attenuated
    Bhattacharya P; Gannavaram S; Ismail N; Saxena A; Dagur PK; Akue A; KuKuruga M; Nakhasi HL
    Pathogens; 2023 Mar; 12(4):. PubMed ID: 37111420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Qualitative differences in the early immune response to live and killed Leishmania major: Implications for vaccination strategies against Leishmaniasis.
    Okwor I; Liu D; Uzonna J
    Vaccine; 2009 Apr; 27(19):2554-62. PubMed ID: 19428861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with Live Attenuated
    Ismail N; Kaul A; Bhattacharya P; Gannavaram S; Nakhasi HL
    Front Immunol; 2017; 8():1788. PubMed ID: 29312315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis.
    Anand S; Madhubala R
    Sci Rep; 2015 Jun; 5():10706. PubMed ID: 26035062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice.
    Elikaee S; Mohebali M; Rezaei S; Eslami H; Khamesipour A; Keshavarz H; Eshraghian MR
    Vaccine; 2019 May; 37(24):3221-3228. PubMed ID: 31047672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Essential Role of Neutrophils in the Protective Immune Response Induced by a Live Attenuated
    Bhattacharya P; Dey R; Saxena A; Karmakar S; Ismail N; Gannavaram S; Dagur PK; Satoskar M; Satoskar S; De Paoli S; Takeda K; McCoy JP; Nakhasi HL
    J Immunol; 2020 Dec; 205(12):3333-3347. PubMed ID: 33177159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of prime and prime-boost immunization strategies in BALB/c mice inoculated with Leishmania infantum transfected with toxic plasmids.
    Augusto Sanches Roque G; Esteves Zorgi N; Janaína Soares Rocha F; Flóro E Silva M; Fernanda Araújo T; Ruiz Abánades D; Giorgio S
    Vaccine; 2022 Jul; 40(31):4105-4115. PubMed ID: 35660330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of Innate Immune Mechanisms to Enhance Leishmania Vaccine-Induced Immunity: Role of Coinhibitory Molecules.
    Gannavaram S; Bhattacharya P; Ismail N; Kaul A; Singh R; Nakhasi HL
    Front Immunol; 2016; 7():187. PubMed ID: 27242794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development.
    Volpedo G; Pacheco-Fernandez T; Bhattacharya P; Oljuskin T; Dey R; Gannavaram S; Satoskar AR; Nakhasi HL
    Front Immunol; 2021; 12():748325. PubMed ID: 34712235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of cross-protection by genetically modified live-attenuated Leishmania donovani parasites against Leishmania mexicana.
    Dey R; Natarajan G; Bhattacharya P; Cummings H; Dagur PK; Terrazas C; Selvapandiyan A; McCoy JP; Duncan R; Satoskar AR; Nakhasi HL
    J Immunol; 2014 Oct; 193(7):3513-27. PubMed ID: 25156362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression analysis of centrin gene in promastigote and amastigote forms of leishmania infantum iranian isolates: a promising target for live attenuated vaccine development against canine leishmaniasis.
    Abbaszadeh Afshar MJ; Elikaee S; Saberi R; Mohtasebi S; Mohebali M
    BMC Vet Res; 2021 Apr; 17(1):162. PubMed ID: 33853591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeated inoculation of killed Leishmania major induces durable immune response that protects mice against virulent challenge.
    Okwor I; Kuriakose S; Uzonna J
    Vaccine; 2010 Jul; 28(33):5451-7. PubMed ID: 20558242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene deleted live attenuated Leishmania vaccine candidates against visceral leishmaniasis elicit pro-inflammatory cytokines response in human PBMCs.
    Avishek K; Kaushal H; Gannavaram S; Dey R; Selvapandiyan A; Ramesh V; Negi NS; Dubey US; Nakhasi HL; Salotra P
    Sci Rep; 2016 Sep; 6():33059. PubMed ID: 27624408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity.
    Saini S; Ghosh AK; Das S; Singh R; Abhishek K; Verma S; Kumar A; Mandal A; Purkait B; Sinha KK; Das P
    Vaccine; 2018 Feb; 36(9):1190-1202. PubMed ID: 29395522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination with Live Attenuated L. Major and TLR4 Agonist Promotes a Th1 Immune Response and Induces Protection against L. Major Infection in BALB/c Mice.
    Noorpisheh Ghadimi S; Farjadian S; Hatam GR; Kalani M; Sarkari B
    Iran J Immunol; 2018 Jun; 15(2):74-83. PubMed ID: 29947337
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.